Sarepta Therapeutics Inc (SRPT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$21.30

Buy

$21.53

arrow-down$-0.22 (-1.01%)

Prices updated at 13 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	1,243m	1,902m
	1,093m	1,583m
	-268m	218m
	-21.54	11.47
	-536m	235m
	-454m	317m
Sales, General and administrative	482m	558m
Interest expenses	22m	18m
Provision for income taxes	16m	26m
Operating expenses	1,361m	1,365m
Income before taxes	-520m	261m
Net income available to common shareholders	-536m	235m
	-5.8	2.34
Net interest income	64m	53m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-5.8	2.34
Free cash flow per share	-6.9418	-4.7744
Book value/share	8.1547	12.6013
Debt equity ratio	1.481933	0.870302

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	2,579m	3,073m
Current liabilities	654m	732m
Total capital	1,992m	2,665m
Total debt	1,397m	1,343m
Total equity	859m	1,528m
Total non current liabilities	-	-
Loans	1,133m	1,137m
Total assets	3,265m	3,963m
Total liabilities	-	-
Cash and cash equivalents	428m	1,103m
Common stock	94m	97m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	986m	444m
Cash dividends paid	-	-
	-588m	-353m
Investments (gains) losses	-166m	756m
	444m	1,119m
Net income	-	-
	-501m	-206m
	-87m	-147m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.